Tech Company Financing Transactions

Avid Radiopharmaceuticals Funding Round

On 5/9/2007, Avid Radiopharmaceuticals raised $26 million in Series C investment from AllianceBernstein, Safeguard Scientifics and BioAdvance Ventures.

Transaction Overview

Company Information

Company Status

Acquired or Merged

Industry

Biopharmaceutical

Mailing Address

3711 Market St. 710
Philadelphia, PA 19104
USA

Phone

(215) 966-6208

Website

www.avidrp.com

Email Address

[email protected]

Overview

Avid Radiopharmaceuticals, Inc. is a clinical-stage product-focused molecular imaging company that has assembled world-class expertise and IP in the field of molecular brain imaging. Avid has developed proprietary radiopharmaceuticals to image amyloid plaques and is currently testing these agents in clinical trials for the detection of Alzheimer's disease.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Daniel Skovronsky

        

Chief Financial Officer

Richard Baron

        

Chief Scientific Officer

Franz Hefti

        

Vice President

Michael Pontecorvo

        

VP - Bus. Development

Alan Carpenter

        

VP - Manufacturing

Paul Kennedy

        

Browse more venture capital transactions:

Prev: 5/9/2007: NetEffect venture capital transaction
Next: 5/9/2007: Brightdoor venture capital transaction

Share this article

Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary